Risk of breast cancer in ataxia–telangiectasia

New England Journal of Medicine

Volumn 326, Issue 20, 1992, Pages 1357-1361

  Bridges, Bryn A ^a   Arlett, Colin F ^a   Kuller, Lewis H ^b   Modan, Baruch ^c   Boice, John D ^d   Miller, Robert W ^d   Wagner, Louis K ^e   Hall, Eric J ^f   Geard, Charles R ^f   Brenner, David J ^f   Land, Charles E ^d   Swift, Michael ^g   Morrell, Daphne ^g   Massey, Ruby B ^g   Chase, Charles L ^g  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f Och Spine at New York Presbyterian Hospitals   (United States)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ATAXIA TELANGIECTASIA; BREAST TUMOR; FEMALE; HUMAN; METHODOLOGY; NOTE; RADIATION INJURY; AGED; RISK; RADIATION DOSE; AGE; BREAST CANCER; CANCER RISK; COMPARATIVE STUDY; CONTROL SYSTEM; DISEASE PREDISPOSITION; HETEROZYGOSITY; LETTER; PATIENT SELECTION; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; SAMPLE;

ADULT; ATAXIA TELANGIECTASIA; BREAST NEOPLASMS; FEMALE; HUMAN; NEOPLASMS, RADIATION-INDUCED; RESEARCH DESIGN; AGED; MIDDLE AGE; RISK; RADIATION DOSAGE;

ORAL CONTRACEPTIVE AGENT;

EID: 0004414749     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199205143262011     Document Type: Letter

References (66)

1. Swift M., Morrell D., Massey R.B., Chase C.L. Incidence of cancer in 161 families affected by ataxia—telangiectasia. N Engl J Med 1991; 325:1831-1836
2. Pippard E.C., Hall A.J., Barker D.J., Bridges B.A. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 1988; 48:2929-2932
3. Borresen A.-L., Andersen T.I., Tretli S., Heiberg A., Moller P. Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chromosom Cancer 1990; 2:339-340
4. Chilvers C.E.D., Deacon J.M. Oral contraceptives and breast cancer. Br J Cancer 1990; 61:1-4.
5. Delarue N.C., Gale G., Ronald A. Multiple fluoroscopy of the chest: carcinogenicity for the female breast and implications for breast cancer screening programs. Can Med Assoc J 1975; 112:1405-1413
6. Modan B., Chetrit A., Alfandary E., Katz L. Increased risk of breast cancer after low-dose irradiation. Lancet 1989; 1:629-631
7. Levin S., Gottfried E., Cohen M. Ataxia telangiectasia: a review with observations on 47 Israeli cases. Pediatrician 1977; 6:135-146
8. Ron I., Modan B., Boice J.D. Jr. Mortality after radiotherapy for ringworm of the scalp. Am J Epidemiol 1988; 127:713-725
9. Kereiakes J.G., Rosenstein M. Handbook of radiation doses in nuclear medicine and diagnostic x-ray. Boca Raton, Fla.: CRC Press, 1980.
10. Tokunaga M., Land C.E., Yamamoto T., et al. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950–1980. Radiat Res 1987; 112:243-272
11. Miller A.B., Howe G.R., Sherman G.J., et al. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med 1989; 321:1285-1289
12. Boice J.D. Jr., Preston D., Davis F.G., Monson R.R. Frequent chest x-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res 1991; 125:214-222
13. Shapiro S., Venet W., Strax P., Venet L. Periodic screening for breast cancer: the Health Insurance Plan project and its sequelae, 1963—1986. Baltimore: Johns Hopkins University Press, 1988.
14. Tabar L., Fagerberg G., Duffy S.W., Day N.E. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health 1989; 43:107-114
15. Borresen A.-L., Andersen T.I., Tretli S., Heiberg A., Moller P. Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chromosom Cancer 1990; 2:339-340
16. Morrell D., Chase C.L., Swift M. Cancers in 44 families with ataxia—telangiectasia. Cancer Genet Cytogenet 1990; 50:119-123
17. Pippard E.C., Hall A.J., Barker D.J., Bridges B.A. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 1988; 48:2929-2932
18. Furth J., Furth O.B. Neoplastic diseases produced in mice by general irradiation with x-rays. I. Incidence and types of neoplasms. Am J Cancer 1936; 28: 54-65.
19. Modan B., Chetrit A., Alfandary E., Katz L. Increased risk of breast cancer after low-dose irradiation. Lancet 1989; 1:629-631
20. Shore R.E., Hildreth N., Woodard E., Dvoretsky P., Hempelmann L., Pasternak B. Breast cancer among women given x-ray therapy for acute postpartum mastitis. J Natl Cancer Inst 1986; 77:689-696
21. Hrubec Z., Boice J.D. Jr., Monson R.R., Rosenstein M. Breast cancer after multiple chest fluoroscopies: second follow-up of the Massachusetts women with tuberculosis. Cancer Res 1989; 49:229-234
22. Miller A.B., Howe G.R., Sherman G.J., et al. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med 1989; 321:1285-1289
23. Shimizu Y., Kato H., Schull W.J., Preston D.L., Fujita S., Pierce D.A. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950–1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses Radiat Res 1989; 118: 502-24.
24. National Research Council. Health effects of exposure to low levels of ionizing radiation. BEIR 5. Washington, D.C.: National Academy Press, 1990.
25. Paterson M.C., Anderson A.K., Smith B.P., Smith P.J. Enhanced radiosensitivity of cultured fibroblasts from ataxia telangiectasia heterozygotes manifested by defective colony-forming ability and reduced DNA repair replication after hypoxic γ-irradiation. Cancer Res 1979; 39:3725-3734
26. Kinsella T.J., Mitchell J.B., McPherson S., Russo A., Tietze F. In vitro x-ray sensitivity in ataxia telangiectasia homozygote and heterozygote skin fibroblasts under oxic and hypoxic conditions. Cancer Res 1982; 42:3950-3956
27. Cole J., Arlett C.F., Green M.H., et al. Comparative human cellular radiosensitivity. II. The survival following gamma-irradiation of unstimulated (G0) T-lymphocytes, T-lymphocyte lines, lymphoblastoid cell lines and fibroblasts from normal donors, from ataxia-telangiectasia patients and from ataxia-telangiectasia heterozygotes. Int J Radiat Biol 1988; 54:929-943
28. Weeks D.E., Paterson M.C., Lange K., et al. Assessment of chronic γ radiosensitivity as an in vitro assay for heterozygote identification of ataxia-telangiectasia. Radiat Res 1991; 128:90-99
29. Blocher D., Sigut D., Hannan M.A. Fibroblasts from ataxia telangiectasia (AT) and AT heterozygotes show an enhanced level of residual DNA double-strand breaks after low dose-rate γ-irradiation as assayed by pulsed field gel electrophoresis. Int J Radiat Biol 1991; 60:791-802.
30. Nagasawa H., Latt S.A., Lalande M.E., Little J.B. Effects of X-irradiation on cell-cycle progression, induction of chromosomal aberrations and cell killing in ataxia telangiectasia (AT) fibroblasts. Mutat Res 1985; 148:71-82.
31. Little J.B., Nagasawa H. Effect of confluent holding on potentially lethal damage repair, cell cycle progression, and chromosomal aberrations in human normal and ataxia-telangiectasia fibroblasts. Radiat Res 1985; 101:81-93.
32. Parshad R., Sanford K.K., Jones G.M., Tarone R.E. G2 chromosomal radiosensitivity of ataxia-telangiectasia heterozygotes. Cancer Genet Cytogenet 1985; 14:163-168
33. Bender M.A., Rary J.M., Kale R.P. G2 chromosomal radiosensitivity in ataxia telangiectasia lymphocytes. Mutat Res 1985; 152:39-47.
34. Hoffman D.A., Lonstein J.E., Morin M.M., Visscher W., Harris B.S. III, Boice J.D. Jr. Breast cancer in women with scoliosis exposed to multiple diagnostic x rays. J Natl Cancer Inst 1989; 81:1307-1312
35. National Research Council. Health effects of exposure to low levels of ionizing radiation. BEIR 5. Washington, D.C.: National Academy Press, 1990.
36. National Council on Radiation Protection and Measurements. Exposure of the U.S. population from diagnostic medical radiation: recommendations of the National Council on Radiation Protection and Measurements. Bethesda, Md.: The Council, 1989. (NCRP report no. 100.)
37. Shore R.E. Carcinogenic effects of radiation on the human breast. In: Upton AC, Albert RE, Burns FJ, Shore RE, eds. Radiation carcinogenesis. New York: Elsevier, 1986.
38. Kereiakes J.G., Rosenstein M. Handbook of radiation doses in nuclear medicine and diagnostic x-ray. Boca Raton, Fla.: CRC Press, 1980.
39. Pippard E.C., Hall A.J., Barker D.J., Bridges B.A. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 1988; 48:2929-2932
40. Borresen A.-L., Andersen T.I., Tretli S., Heiberg A., Moller P. Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chromosom Cancer 1990; 2:339-340
41. Swift M., Morrell D., Massey R.B., Chase C.L. Incidence of cancer in 161 families affected by ataxia—telangiectasia. N Engl J Med 1991; 325:1831-1836
42. Modan B., Chetrit A., Alfandary E., Katz L. Increased risk of breast cancer after low-dose irradiation. Lancet 1989; 1:629-631
43. Kleinbaum D.G., Kupper L.L., Morgenstern H. Epidemiologic research: principles and quantitative methods. Belmont, Calif.: Lifetime Learning Publications, 1982.
44. Rothman K.J., Boice J.D. Jr. Epidemiologic analysis with a programmable calculator. Washington, D.C.: Government Printing Office, 1979. (NIH publication no. (DHEW) 79–1649.)
45. Swift M., Reitnauer P.J., Morrell D., Chase C.L. Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 1987; 316:1289-1294
46. Boice J.D. Jr., Monson R.R. Breast cancer in women after repeated fluoroscopic examinations of the chest. J Natl Cancer Inst 1977; 59:823-832
47. Taylor K.W., Patt N.L., Johns H.E. Variations in x-ray exposure to patients. J Can Assoc Radiol 1979; 30:6-11.
48. Heggie J.C.P. A survey of doses to patients in a large public hospital resulting from common plain film radiographic procedures. Australas Phys Eng Sci Med 1990; 13:71-80.
49. Spector B.D., Filipovich A.H., Perry G.S. III, Kersey J.H. Epidemiology of cancer in ataxia-telangiectasia. In: Bridges BA, Harnden DG, eds. Ataxia-telangiectasia: a cellular and molecular link between cancer, neuropathology, and immune deficiency. Chichester, England: John Wiley, 1982: 103-38.
50. Lambert W.C., Kolber D.R., Gorelli L.A., Muglia J.J., Kardashian J.F. Epidermoid carcinoma of the oral cavity following diagnostic roentgenographic examination in a patient with ataxia-telangiectasia. Clin Prevent Dent 1982; 4(6):3-8.
51. Miller A.B., Howe G.R., Sherman G.J., et al. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med 1989; 321:1285-1289
52. Hoffman D.A., Lonstein J.E., Morin M.M., Visscher W., Harris B.S. III, Boice J.D. Jr. Breast cancer in women with scoliosis exposed to multiple diagnostic x rays. J Natl Cancer Inst 1989; 81:1307-1312
53. Hendrick R.E. Standardization of image quality and radiation dose in mammography. Radiology 1990; 174:648-654
54. Hildreth N.G., Shore R.E., Dvoretsky P.M. The risk of breast cancer after irradiation of the thymus in infancy. N Engl J Med 1989; 321:1281-1284
55. Baral E., Larsson L.-E., Mattsson B. Breast cancer following irradiation of the breast. Cancer 1977; 40:2905-2910
56. Tokunaga M., Land C.E., Yamamoto T., et al. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950–1980. Radiat Res 1987; 112:243-272
57. Breast cancer screening in women under 50. Lancet 1991; 337:1575-1576
58. Rudolph N.S., Nagasawa H., Little J.B., Latt S.A. Identification of ataxia telangiectasia heterozygotes by flow cytometric analysis of X-ray damage. Mutat Res 1989; 211:19-29.
59. Nagasawa H., Kraemer K.H., Shiloh Y., Little J.B. Detection of ataxia telangiectasia heterozygous cell lines by postirradiation cumulative labeling index: measurements with coded samples. Cancer Res 1987; 47:398-402.
60. Blocher D., Sigut D., Hannan M.A. Fibroblasts from ataxia telangiectasia (AT) and AT heterozygotes show an enhanced level of residual DNA double-strand breaks after low dose-rate gamma-irradiation as assayed by pulsed field gel electrophoresis. Int J Radiat Biol 1991; 60:791-802.
61. Paterson M.C., MacFarlane S.J., Gentner N.E., Smith B.P. Cellular hypersensitivity to chronic gamma-radiation in cultured fibroblasts from ataxia-telangiectasia heterozygotes. In: Gatti RA, Swift M, eds. Ataxia-telangiectasia: genetics, neuropathology, and immunology of a degenerative disease of childhood: proceedings of a conference held in Solvang, California, January 16—20, 1984. Kroc Foundation series. Vol. 19. New York: Alan R. Liss, 1985.
62. Shiloh Y., Parshad R., Frydman M., et al. G2 chromosomal radiosensitivity in families with ataxia-telangiectasia. Hum Genet 1989; 84:15-18
63. Pawlak A.L., Kotecki M., Ignatowicz R. Increased frequency of chromatid breaks in lymphocytes of heterozygotes of ataxia telangiectasia after in vitro treatment with caffeine. Mutat Res 1990; 230:197-204.
64. Rosin M.P., Ochs H.D., Gatti R.A., Boder E. Heterogeneity of chromosomal breakage levels in epithelial tissue of ataxia-telangiectasia homozygotes and heterozygotes. Hum Genet 1989; 83:133-138
65. Ries L.A.G., Hankey B.F., Miller B.A., Hartman A.M., Edwards B.K. Cancer statistics review 1973—1988. Bethesda, Md.: National Cancer Institute, 1991. (NIH publication no. 91–2789.)
66. Shore R.E., Hempelmann L.H., Kowaluk E., et al. Breast neoplasms in women treated with x-rays for acute postpartum mastitis. J Natl Cancer Inst 1977; 59:813-822